.png){kind=logo}
™
Unlocking first-in-class biologics with genetics-inspired functional screening at scale.
Our Investors
Empowering today's innovation
Heligenics has been enthusiastically received by both institutional and individual investor communities. We have strong marketing alliances across the USA.
Our InvestorsÂ
Heligenics is backed by Corporate and Individual Investors
University of Nevada Las Vegas
Individuals
Over 60 early investors have backed Heligenics, recognizing our disruptive potential across drug development, repurposing, and clinical trial innovation. Their contributions, while smaller in size, are equally important in helping us drive transformative change in human health.
You
Who We Seek​
-
Are you driven to create meaningful change in how we diagnose and treat disease?
-
Have you experienced the impact of genetics firsthand—personally or through someone you love?
-
Do you want to be part of the next breakthrough in medicine?
​​
We invite conversations with individuals, family offices, and institutional investors who share our belief that genetics and functional genomics will play a defining role in the future of health. If you're passionate about advancing personalized medicine and accelerating innovation, we’d love to connect.